The government added 149 items to the list of strategically…
The government added 149 items to the list of strategically significant medicines that ensure priority healthcare needs. The Russian government expanded the list of strategically important drugs.
Consensus
- The Russian government added 149 drug names to the list of strategically significant medicines.
- The expansion aims to ensure priority supply for healthcare needs, including prevention and treatment of diseases.
- The decision was made based on proposals from pharmaceutical producers.
- The expanded list includes drugs essential for treating serious or socially significant conditions.
- Production of these medicines must be ensured within Russia's territory.
- Medicines in the list have priority in state procurement processes.
Points of divergence
- The expanded list includes specific drugs such as human albumin, diphtheria and tetanus antitoxins, gelatin, immunoglobulins, naloxone, phenobarbital, acyclovir, haloperidol, lidocaine, among others. — kommersant
- The expanded list includes life-saving and critical medicines for treating highly dangerous infections, socially significant diseases, and conditions posing a danger to the environment or public health. — interfax
Coverage (2 sources)
- Russia expands list of strategically significant drugs by nearly 150 items — Коммерсантъ
- Russian Government Expands List of Strategically Significant Medicines — Интерфакс